Accenture plc (ACN)

NYSE: ACN · USD

$171

+0.31 (+0.2%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-08-06 02:00 UTC. Latest published research analyzed 2026-05-10 · historical · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh ACN analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-10

Our latest published analysis: ACN rated Buy

ACN is rated Buy at $180.42 versus the reconciled fair value midpoint of $223.45, implying +23.85% upside/downside. Confidence is separately disclosed at 88/100.

Fair value (mid)

$223 / share

$186 – $261

Upside to FV

+23.9%

from $171

Confidence

88/100

Moat

9/10

Market cap	$111.0B
Revenue (ttm)	73.1B
Net income (ttm)	7.8B
EPS (ttm)	$12.5
Shares out	611.9M
P/E (trailing)	13.7x
P/E (forward)	12.1x
Dividend	$6.52 (3.82%)
Volume	5,392,004
Beta	1.07
Price target	$179	+4.8%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 73.1B
Net income (ttm): 7.8B
EPS (ttm): $12.5
P/E (trailing): 13.7x
P/E (forward): 12.1x
Market cap: $111.0B

Item	P1	P2	P3	P4	Trend
Period	2022-08-31	2023-08-31	2024-08-31	2025-08-31	Trend
Revenue	$61.59B	$64.11B	$64.90B	$69.67B	+4.2%
Gross profit	$19.70B	$20.73B	$21.16B	$22.24B	+4.1%
Operating income	$9.37B	$9.87B	$10.03B	$10.84B	+5.0%
Net income	$6.88B	$6.87B	$7.26B	$7.68B	+3.7%
EPS (diluted)	$10.71	$10.77	$11.44	$12.15	+4.3%
EBITDA	$10.27B	$10.25B	$10.84B	$11.87B	+4.9%
R&D	—	—	—	—	—
SG&A	$10.33B	$10.86B	$11.13B	$11.39B	+3.3%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ABBV	AbbVie Inc.	435.1B	69.6x	6.8x	17.7%	+3.7%	+28.7%	Hold
ABT	Abbott Laboratories	182.9B	34.2x	3.9x	7.5%	+3.0%	-16.8%	Strong Buy
ADI	Analog Devices Inc.	184B	56.2x	14.4x	9.1%	+15.5%	+72.1%	Sell
AAPL	Apple Inc.	4.5T	35.7x	9.7x	101.6%	+6.1%	+53.5%	Sell
ADBE	Adobe Inc.	103.1B	14.8x	4.1x	60.7%	+11.9%	-23.5%	Strong Buy
ADSK	Autodesk Inc.	50.7B	35.1x	6.8x	49.1%	+14.0%	-20.7%	Sell

All ACN indicators

Market & fundamental data

Available fields

292

Groups with data

Currency

USD

Showing 292 of 292 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001467373
Company name	Accenture plc
Country	Ireland
Country code	US
Cusip	G1151C101
Employees	779,000
Employees Change	5,000%
Employees Change Percent	0.65
Enterprise value	$102.7B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Information Technology Services
Industry PE	19.54
Industry PE Fwd	14.14
Isin	IE00B4BNMY34
Last refreshed	2026-08-06
Market cap	$104.5B
Market cap category	Large-Cap
Price	$171
Price currency	USD
Rev Per Employee	93,839.02x
Sector	Technology
Sector PE	35.95
Sector PE Fwd	20.63
Sic	7389
Symbol	ACN
Tags	artificial-intelligence
Website	https://www.accenture.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.46%
EV Earnings	13.18x
EV Sales Forward	1.36x
EV/EBIT	9.7x
EV/EBITDA	7.84x
EV/FCF	8.16x
EV/Sales	1.4x
FCF yield	12.04%
Forward P/E	11.91x
P/B ratio	3.28x
P/E ratio	13.65x
P/S ratio	1.43x
PE Ratio10 Y	26.01x
PE Ratio3 Y	25.39x
PE Ratio5 Y	27.08x
PEG ratio	1.74x
PS Forward	1.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.49%
EBITDA Margin	17.92%
FCF margin	17.21%
Gross margin	32.01%
Gross Profit	$23.4B
Gross Profit Growth	6.56%
Gross Profit Growth Q	5.28%
Gross Profit Growth3 Y	4.52%
Gross Profit Growth5 Y	8.82%
Net Income	$7.8B
Net Income Growth	-2%
Net Income Growth Q	6.44%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	2.83%
Net Income Growth5 Y	6.16%
Pretax Margin	14.57%
Profit Margin	10.66%
Profit Per Employee	$10,000
Profitable Quarters	$99
Profitable Years	28
ROA	10.9
Roa5y	12.03
ROCE	22.44
ROE	24.41
Roe5y	29.03
ROIC	27.09
Roic5y	36.75

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.05%
Cagr15y	9.73%
Cagr1y	-31.85%
Cagr20y	11.39%
Cagr3y	-16.36%
Cagr5y	-9.93%
Div CAGR10	11.48%
Div CAGR3	13.32%
Div CAGR5	13.12%
EPS Growth	-0.48
EPS Growth Q	9.01
EPS Growth Quarters	2
EPS Growth Years	8
EPS Growth3 Y	3.66
EPS Growth5 Y	6.92
FCF Growth	22.82%
FCF Growth Q	2.41%
FCF Growth3 Y	10.28%
FCF Growth5 Y	6.55%
OCF Growth	20.39%
OCF Growth Q	2.76%
OCF Growth10 Y	12.37%
OCF Growth3 Y	10%
OCF Growth5 Y	6.34%
Revenue Growth	6.74x
Revenue Growth Q	5.59x
Revenue Growth Quarters	8x
Revenue Growth Years	15x
Revenue Growth3 Y	4.78x
Revenue Growth5 Y	8.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.11
Assets	$68.8B
Cash	$10.2B
Current Assets	$28.9B
Current Liabilities	$21.6B
Debt	$8.4B
Debt EBITDA	$0.64
Debt Equity	$0.25
Debt FCF	$0.67
Equity	$33.5B
Interest Coverage	39.85
Liabilities	$35.3B
Long Term Assets	$39.9B
Long Term Liabilities	$13.7B
Net Cash	$1.8B
Net Cash By Market Cap	$1.71
Net Cash Growth	21.1%
Net Debt EBITDA	$-0.14
Net Debt Equity	$-0.05
Net Debt FCF	$-0.14
Tangible Book Value	$4.1B
Tangible Book Value Per Share	$6.65
WACC	9.58

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Net Working Capital	$-2B
Quick ratio	1.21
Working Capital	$7.3B
Working Capital Turnover	$9.15

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.53%
Dividend Growth	10.14%
Dividend Growth Years	6%
Dividend per share	$6.52
Dividend Years	22
Dividend Yield	3.82%
Ex Div Date	2026-07-09
Last Dividend	$1.63
Payout Frequency	Quarterly
Payout Ratio	52.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	79.95%
1Y total return	-31.83%
200-day SMA	210
3Y total return	-41.49%
50-day SMA	153.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-40.73%
All Time High	417.4
All Time High Change	-59.09%
All Time High Date	2021-12-29
All Time Low	11.3
All Time Low Change	1,410.88%
All Time Low Date	2002-10-07
ATR	8.16
Beta	1.07
Beta1y	0.44
Beta2y	0.67
Ch YTD	-36.37
High	173.3
High52	291.1
High52 Date	2026-01-14
High52ch	-41.35%
Low	167.4
Low52	118.2
Low52 Date	2026-06-22
Low52ch	44.5%
Ma50ch	11.02%
Premarket Change Percent	1.81
Premarket Price	$174
Premarket Volume	10,145
Price vs 200-day SMA	-18.69%
RSI	64.81
RSI Monthly	36.22
RSI Weekly	43.71
Sharpe ratio	-0.75x
Sortino ratio	-0.86
Total Return	5.35%
Tr YTD	-34.68
Tr15y	302.68%
Tr1m	25.8%
Tr1w	-1.41%
Tr3m	-4.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	27
Analyst Count Top	10
Analyst Price Target Top	$194
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$3.18
Earnings EPS Estimate Growth	4.95
Earnings Revenue Estimate	18,035,002,696x
Earnings Revenue Estimate Growth	2.47x
Operating Income	$11.5B
Operating Income Growth	9.06
Operating Income Growth Q	6.45
Operating Income Growth3 Y	3.26
Operating Income Growth5 Y	9.85
Operating margin	15.77
Price target	$179
Price Target Change	$4.78
Price Target Change Top	$13.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	610,765,465%
Float Percent	99.81%
Shares Insiders	0.06%
Shares Institutions	83.9%
Shares Out	611,942,109
Shares Qo Q	-1.13%
Shares Yo Y	-1.53%
Short Float	5.49%
Short Ratio	2.55
Short Shares	5.48

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$10.5B
Adjusted OCF	11,098,029,000
Average Volume	7,457,545.1x
Bv Per Share	52.12
CAPEX	$-600.4M
Ch10y	50.15
Ch15y	199.6
Ch1m	24.3
Ch1w	-1.41
Ch1y	-34.03
Ch20y	492.2
Ch3m	-5.21
Ch3y	-45.28
Ch5y	-46.1
Ch6m	-29.35
Change	0.18%
Change From Open	-0.88
Close	170.4
Days Gap	1.07
Depreciation Amortization	1,415,510,000
Dollar Volume	920,576,842.9
Earnings Date	2026-09-24
Earnings Time	bmo
EBIT	$10.6B
EBITDA	$13.1B
EPS	$12.5
F Score	5
FCF	$12.6B
FCF EV Yield	12.25x
FCF Per Share	$20.56
Financing CF	-8,365,634,000
Fiscal Year End	August
Founded	1,989
Goodwill	25,322,800,000
Graham Number	121.08911
Graham Upside	-29.08
Income Tax	$2.7B
Investing CF	-4,223,595,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-06-18
Last Report Date	2026-05-31
Last Split Type	Never
Last10k Filing Date	2025-10-10
Lynch Fair Value	$76.96
Lynch Upside	-54.92
Ma150	194.7
Ma150ch	-12.33%
Ma20	150.6
Ma20ch	13.37%
Net CF	533,638,000
Next Earnings Date	2026-09-24
Open	172.3
Optionable	Yes
P FCF Ratio	8.3
P FCF Ratio SBC	9.95
P OCF Ratio	7.93
P OCF Ratio SBC	9.41
Payment Date	2026-08-14
Position In Range	56.43
Post Close	170.7
Postmarket Change Percent	-1.24
Postmarket Price	$169
Ppne	4,593,511,000
Pre Close	170.4
Price Date	2026-08-05
Price EBITDA	$7.97
Ptbv Ratio	25.68
Relative Volume	0.72x
Revenue	73,100,594,000x
SBC By Revenue	2.85x
Share Based Comp	2,084,065,000
Tax By Revenue	3.71x
Tax Rate	25.45%
Tr20y	764.94%
Tr6m	-27.89%
Views	487
Volume	5,392,004
Z Score	4.79

Frequently asked questions

About this ACN report

What is the latest published ACN stock rating?

Accenture plc is shown with buy in the latest published report, analyzed 2026-05-10. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACN analysis?

The full latest published report, analyzed 2026-05-10, lives at /stocks/ACN/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for ACN?

The latest published report analyzed 2026-05-10 frames ACN around USD 186 to USD 261. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the ACN page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-10). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Accenture plc (ACN)

Coverage state: Latest published research available

Generate a fresh ACN analysis

Our latest published analysis: ACN rated Buy

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · ACN

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All ACN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on ACN

Frequently asked questions